GoodRx Holdings, Inc. Class A Common Stock (GDRX)
NASDAQ · Healthcare
GoodRx Holdings, Inc. Class A Common Stock Revenue 2020–2025
GoodRx Holdings, Inc. Class A Common Stock annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- GoodRx Holdings, Inc. Class A Common Stock revenue for the quarter ending March 31, 2026 was 194.0 M.
- GoodRx Holdings, Inc. Class A Common Stock revenue for the twelve months ending March 31, 2026 was 787.9 M.
- GoodRx Holdings, Inc. Class A Common Stock annual revenue for 2025 was 796.9 M, a 0.57% increase from 2024.
- GoodRx Holdings, Inc. Class A Common Stock annual revenue for 2024 was 792.3 M, a 5.61% increase from 2023.
- GoodRx Holdings, Inc. Class A Common Stock annual revenue for 2023 was 750.3 M, a 2.12% decrease from 2022.
- GoodRx Holdings, Inc. Class A Common Stock annual revenue for 2022 was 766.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GoodRx Holdings, Inc. Class A Common Stock Market Cap — FAQ
GoodRx Holdings, Inc. Class A Common Stock (GDRX) market cap over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GDRX's market cap history?
The chart and table above show GoodRx Holdings, Inc. Class A Common Stock's market cap by year and by quarter, including the growth rate.